Hungarian researcher Botond Roska, based in Basel, Switzerland, discovered a gene-based therapy that reactivates the retinas in blind people. The procedure reprogramed cells in the human eye to perform the work of the light-sensitive receptors needed for human vision. Preliminary results indicated that this process would allow blind people to have vision similar to watching television in black and white. Roska was awarded the 2020 Körber Prize for European Science, along with €1 million ($1.18 million) in prize money from the Körber Foundation, based in Hamburg, Germany.

Read Full Story